Caplyta 21 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FYBXM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,139
Award facts
- Contract value 100% obligated
- $2,138.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of CAPLYTA 21 mg capsules (30-count) valued at $2,138.70 under a firm fixed-price contract. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The award was made without a set-aside designation through competitive procedures, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements. CAPLYTA (lumateperone) is an atypical antipsychotic medication used in treating psychiatric conditions, and will be performed at the contractor's Conshohocken, Pennsylvania facility.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems through its comprehensive federal contract portfolio. The SPE2DX IDC functions as a global pharmaceutical support vehicle enabling supply of a broad range of medications, vaccines, and medical supplies to support Defense Health Agency and other federal healthcare programs worldwide. Through this flexible contract vehicle, AmerisourceBergen continues to fulfill varied federal medical supply needs across multiple therapeutic domains, with individual delivery orders ranging substantially in value while maintaining consistent firm fixed-price terms and competitive award practices.
Quick answers
Who was awarded contract SPE2DB25FYBXM?
SPE2DB25FYBXM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FYBXM worth?
The government has obligated $2,139 on SPE2DB25FYBXM.
Is contract SPE2DB25FYBXM an order under another contract?
Yes. SPE2DB25FYBXM is a delivery order under SPE2DB20D3505, an indefinite delivery contract.
Was contract SPE2DB25FYBXM competed?
The extent of competition for SPE2DB25FYBXM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award